A NITI Aayog report outlines India's potential to scale its bioeconomy to USD 691 billion by 2035 and USD 2.6 trillion by 2047, creating over 30 million high-value jobs. The report stresses the need for coordinated national execution, regulatory reforms, a strengthened talent pipeline, and a significant BioEconomy Growth Fund to achieve this vision, positioning India among the top biotechnology powers globally.
Researchers at IIT-Guwahati have identified a type of blue-green algae (cyanobacteria) that can effectively remove lead from contaminated water. The study highlights the role of exopolysaccharides (EPS) produced by the algae in absorbing lead, with laboratory experiments showing up to 66.2% removal. This discovery offers a promising, naturally abundant solution for water purification, though further validation is needed before commercial application.
Bharti Airtel added 7.64 trillion in value over the past five years, making it the biggest wealth creator in India's private sector, while the IT sector, including TCS, Infosys, and Wipro, collectively lost 8.5 trillion in value, according to the latest Burgundy Private Hurun India 500 report.
IIT-Guwahati has partnered with Kaashyap Cleantech Innovations to commercialise bio-methanol production technology, which converts greenhouse gases into a versatile liquid fuel, offering environmental and performance benefits.
A new MoU between the Centre for Cellular and Molecular Platforms (C-CAMP) and Imperial College London has paved the way for deepening India-UK ties in the life sciences sector.
A new study reveals that insects' lightning-fast reactions are due to a 'turbo boost' feature in their brains, which could inspire more energy-efficient robots and self-driving cars.
Ajay Kela, CEO of Wadhwani Foundation, highlights India's significant opportunity to lead in the diffusion of technology, creating national-scale use cases that reach millions of end-users. He also discusses the role of deep-tech startups and SMEs in job creation and the importance of upskilling initiatives.
The 2025 contraction marks the steepest decline in both the number of billionaire promoters and their aggregate wealth since 2012.
If Xi Jinping is dethroned in the future, the instrument for that may well be embedded within the PLA, notes former foreign secretary Shyam Saran.
Prices for Indian consumers are expected to come down significantly from the current Rs 17,000-Rs 26,000 monthly.
Covid is growing milder with time but an occasional surge in cases is expected because the virus that causes it is now endemic and constantly evolving, say scientists while assuring that there is no cause for concern.
IIT Bombay's alumni raised a whopping $7 million for their alma mater at a function to celebrate 50 years of the premier institution to set up a bioscience centre.
The student was detained three days after the ISIS India head Haris Farooqi alias Harish Ajmal Farukhi and his associate Anurag Singh alias Rehan were arrested in Dhubri district after they had crossed over from Bangladesh.
The transmission of dengue is closely associated with three key factors -- rainfall, humidity and temperature -- that dictate the geographies in which it spreads and the transmission rate of the viral infection caused by the dengue virus (DENV), and transmitted to humans through the bite of infected mosquitoes.
Sun Pharmaceutical Industries on Tuesday said its arm DUSA Pharmaceuticals Inc has reached settlement with Biofrontera to resolve a litigation over misappropriation of trade secrets and unfair practice, following which DUSA will receive $22.5 million (nearly Rs 170 crore). In 2018, DUSA Pharmaceuticals had filed a suit at the US District Court of Massachusetts against Biofrontera Inc Biofrontera Bioscience GmbH, Biofrontera Pharma GmbH, and Biofrontera AG (together known as Biofrontera) alleging "misappropriation of trade secrets, tortious interference of contract and unfair trade practices".
As concerns mounted and some people wondered whether this could possibly turn out to be another Covid, pulmonologist Anurag Agrawal said he doesn't expect to see a massive wave.
Lumpy Skin Disease has spread in more than a dozen states including Gujarat, Rajasthan, Punjab and Haryana.
GVK Biosciences is the latest Indian firm to come under international scrutiny over quality issues.
Ajit Mishra, vice president, Research, Religare Broking, answers your queries.
Vaccine major Serum Institute of India on Tuesday said the approval for the COVID-19 vaccine 'Covovax' would strengthen immunization initiatives across India and various lower and middle income countries across the world.
This State-corporate 'cooperation' didn't begin with the arrival of the Modi government.
Many of the big licences, contracts, and even environmental clearances for the Adani group had come in the UPA's time, points out Shekhar Gupta.
Bharat Biotech has completed the Phase 2/3 trials of COVID-19 vaccine, Covaxin for use in children under 18 years of age and is expected to submit the data by next week to the Drugs Controller General of India (DCGI), Chairman and Managing Director of Bharat Biotech International Ltd, Krishna Ella said
Senior virologist Shahid Jameel on Sunday resigned as the chairman of scientific advisory group of Indian SARS-CoV-2 Genomics Consortium, a forum set up by union government in December last year for laboratory and epidemiological surveillance of circulating strains of COVID-19 in India.
In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.
Germany's drug regulator has banned the sale of 80 generic medicines with immediate effect on the grounds that their clinical trials conducted by India's pharmaceutical research company GVK Biosciences were "insufficient".
The joint drug-discovery project of multinational pharma firm Wyeth and GVK Biosciences will fully take off within a month's time, following the establishment of a dedicated discovery chemistry research laboratory.
As part of its global expansion plans, Dabur Pharma has acquired the sales and distribution network of Thailand-based Bioscience for an undisclosed sum.
The plant and associated facilities focus on manufacturing or packaging Amoxicilin-based products, which include semi-synthetic penicillin
Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.
Indian pharma firms under European drug regulator's scanner.
Negotiators from were expected to meet in New Delhi on August 28.
The Union health ministry on Friday said license has been given to five more manufacturers for production of Amphotericin-B, used in the treatment of black fungus, and they will start producing 1,11,000 vials of the drug per month from July.
The identification of host dependency factors mediating virus infection may provide key insights into effective molecular targets for developing broadly acting antiviral therapeutics against SARS-CoV-2 and other deadly coronavirus strains, according to the researchers.
If the pandemic persists, at least a portion of the blame should go to greed and nationalism that got in the way of the world acting together, notes Prosenjit Datta.
500 million doses per annum from its two sites in Hyderabad and 200 million doses each from its Ankleshwar and Kolar facilities.
To address the shortage of COVID-19 jabs in the country, the government is exploring the possibility of boosting production of vaccines, including identifying manufacturing sites for indigenously developed Covaxin outside India, sources said.
Ajit Mishra, vice president, research, Religare Broking, answers your queries.
While Covishield supplies would meet the target of 500 mn doses between August and December, it looks like Covaxin would miss the target of 400 mn unless the partner sites of Bharat Biotech ramp up very rapidly, reports Sohini Das.
Ajit Mishra, vice president, research, Religare Broking, answers your stockmarket queries.
There is so far no evidence that the second wave of COVID-19 in the country is due to variants of the virus, but it is possible, said noted virologist Shahid Jameel.
